Key result
Nonalcoholic fatty liver disease was associated with a higher risk of atrial fibrillation compared to controls, with the increased risk predominantly seen in patients with type 2 diabetes.
Why the study?
Does nonalcoholic fatty liver disease increase the risk of atrial fibrillation?
Meta-Analysis (n=5,150)
Does nonalcoholic fatty liver disease increase the risk of atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Ultrasound-diagnosed NAFLD is associated with a significantly increased risk of atrial fibrillation, particularly in patients with type 2 diabetes.
INTRODUCTION: Numerous epidemiologic studies have investigated the link between nonalcoholic fatty liver disease (NAFLD) and long-term atrial fibrillation (AF) risk, but the results are surprisingly conflicting. AIM: Therefore, we systematically reviewed all published studies assessing the risk of AF in patients with NAFLD and conducted a meta-analysis. MATERIAL AND METHODS: We performed a literature search using PubMed, EMBASE and Cochrane Library databases in February 2017 with no restrictions. Two cohort studies and two cross-sectional studies were identified, involving a total of 5150 subjects (NAFLD: 1655; controls: 3495) in this meta-analysis. Data from selected studies were extracted and a meta-analysis was performed using a random effects model. CONCLUSIONS: Our meta-analysis suggested that ultrasound-diagnosed NAFLD patients have a significantly higher risk for AF after adjustment for numerous important clinical risk factors for AF. These results need to be confirmed in large prospective studies.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2017) conducted a meta-analysis in Nonalcoholic fatty liver disease (NAFLD) (n=5,150). Nonalcoholic fatty liver disease vs. Controls without NAFLD was evaluated on Atrial fibrillation (RR 2.61, 95% CI 1.34-5.06, p=0.00). Nonalcoholic fatty liver disease was associated with a higher risk of atrial fibrillation compared to controls, with the increased risk predominantly seen in patients with type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: